MedTrace Logo

Endovascular Treatment of Atherosclerotic Lesions in the SFA Using the Sinus-superflex-635 Stent

NCT01816854 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 117

Last updated 2018-12-20

No results posted yet for this study

Summary

In this prospective study, a newly developed self-expanding nitinol stent is evaluated for the treatment of atherosclerotic lesions in the superficial femoral artery and proximal popliteal artery.

Conditions

  • Atherosclerotic Heart Disease

Interventions

DEVICE

Stenting

Sponsors & Collaborators

  • be Medical

    lead INDUSTRY

Principal Investigators

  • Jeroen Hendriks, MD, PhD · University Hospital, Antwerp

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-08
Primary Completion
2017-03-29
Completion
2017-03-29

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01816854 on ClinicalTrials.gov